Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Uterine Cervical Neoplasms 10Neoplasms 9Breast Neoplasms 9Colorectal Neoplasms 8Lung Neoplasms 5Papillomavirus Infections 3Uterine Cervical Dysplasia 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Heart Diseases 2HIV Infections 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2End Stage Liver Disease 2the Rate of Participation in Screening for PBC 1Warts 1Venous Thromboembolism 1Uterine Cervical Diseases 1Urinary Bladder Neoplasms 1Tinea 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Skin Neoplasms 1Retinoblastoma 1Radiation Injuries 1Pulmonary Atelectasis 1Postural Orthostatic Tachycardia Syndrome 1Postoperative Complications 1

Interventions

Cyclophosphamide 78fludarabine phosphate 77Azacitidine 76Peripheral Blood Stem Cell Transplantation 63Busulfan 53Mycophenolic Acid 51Whole-Body Irradiation 50Tacrolimus 48Cytarabine 43Cyclosporine 43Methotrexate 37Decitabine 36Filgrastim 32Antilymphocyte Serum 30venetoclax 27Radiotherapy 25Melphalan 23fludarabine 22Etoposide 18Methylprednisolone 17Biopsy 15Cyclosporins 14Specimen Handling 13Injections 13Granulocyte Colony-Stimulating Factor 13Flow Cytometry 13Cord Blood Stem Cell Transplantation 13decitabine and cedazuridine drug combination 12Idarubicin 12Stem Cell Transplantation 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myelomonocytic, Chronic × Mass Screening × Clear all
NCT07143669 2026-05-22

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Blueprint Medicines Corporation

Recruiting
450 enrolled
MyeloidOther hematologic neoplasm

Mastocytosis, Leukemia, Myelomonocytic, Chronic, Postural Orthostatic Tachycardia Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡